Total SA (EPA:FP) Given Average Recommendation of "Buy" by Analysts

Claudine Rigal
Août 13, 2017

(The) in a research note issued to investors on Tuesday, August 1st. Finally, Societe Generale set a €85.90 ($101.06) price target on Vinci SA and gave the stock a neutral rating in a research note on Saturday, May 20th. Morgan Stanley set a €50.00 ($58.82) price objective on Total SA and gave the company a "neutral" rating in a research report on Monday, April 24th. Two analysts have rated the stock with a sell rating, ten have given a hold rating and five have assigned a buy rating to the stock. The brokerage presently has a "buy" rating on the stock.

Shares of Total SA (EPA:FP) have received an average rating of "Buy" from the fifteen ratings firms that are now covering the firm, MarketBeat Ratings reports. Kepler Capital Markets set a €92.00 ($108.24) price target on shares of Sanofi SA and gave the company a "buy" rating in a report on Wednesday, April 12th. Societe Generale set a €85.90 ($101.06) price target on Vinci SA and gave the company a neutral rating in a research note on Wednesday, May 10th. Morgan Stanley set a €21.00 ($24.71) price target on shares of Vivendi SA and gave the stock a buy rating in a research note on Friday, May 12th.

Sanofi SA (EPA:SAN) traded down 0.25% during midday trading on Tuesday, reaching €80.60. The firm's 50 day moving average is €25.48 and its 200-day moving average is €25.74. Total SA has a 12 month low of €40.53 and a 12 month high of €49.50. The firm has a market cap of €101.21 billion and a price-to-earnings ratio of 11.24.

WARNING: "Total SA (FP) Given a €46.50 Price Target by Jefferies Group LLC Analysts" was originally reported by TheOlympiaReport and is the sole property of of TheOlympiaReport. "(The) Analysts" was posted by Community Financial News and is owned by of Community Financial News.

If you are viewing this story on another site, it was copied illegally and republished in violation of United States and worldwide trademark & copyright law. If you are reading this report on another site, it was copied illegally and republished in violation of United States & global copyright and trademark law.

Sanofi is a healthcare company, focused on patient needs and engaged in the research, development, manufacture and marketing of therapeutic solutions. The company operates through three segments: Upstream, Refining & Chemicals, and Marketing & Services.

D'autres rapports CampDesrEcrues

Discuter de cet article

SUIVRE NOTRE JOURNAL